Provided by Tiger Trade Technology Pte. Ltd.

Solid Biosciences

7.11
-0.6200-8.02%
Post-market: 7.250.1400+1.97%19:07 EDT
Volume:826.58K
Turnover:5.98M
Market Cap:699.56M
PE:-3.57
High:7.92
Open:7.73
Low:7.05
Close:7.73
52wk High:8.72
52wk Low:2.41
Shares:98.39M
Float Shares:58.54M
Volume Ratio:0.81
T/O Rate:1.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9922
EPS(LYR):-3.0550
ROE:-109.90%
ROA:-53.18%
PB:3.89
PE(LYR):-2.33

Loading ...

Solid Biosciences Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 25

J.P. Morgan Issues a Buy Rating on Solid Biosciences (SLDB)

TIPRANKS
·
Mar 25

Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Apogee Therapeutics (APGE) and Solid Biosciences (SLDB)

TIPRANKS
·
Mar 23

Solid Biosciences Price Target Maintained With a $20.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 23

Solid Biosciences: Strong SGT-003 Clinical Profile, Emerging Pipeline, and Robust Cash Runway Underpin Buy Rating

TIPRANKS
·
Mar 23

Evolving Tax Rules and New Excise Levies Threaten Solid Biosciences’ Profitability and Cash Flows

TIPRANKS
·
Mar 21

Guggenheim Initiates Solid Biosciences at Buy With $26 Price Target

MT Newswires Live
·
Mar 20

Analysts Conflicted on These Healthcare Names: MoonLake Immunotherapeutics (MLTX), Solid Biosciences (SLDB) and Merck & Company (MRK)

TIPRANKS
·
Mar 20

Solid Biosciences initiated with a Buy at Guggenheim

TIPRANKS
·
Mar 20

Solid Biosciences Price Target Maintained With a $19.00/Share by Needham

Dow Jones
·
Mar 20

Solid Biosciences: De-Risking Duchenne Program and Advancing Gene Therapy Pipeline Supports Buy Rating and $19 Target

TIPRANKS
·
Mar 20

Solid Biosciences (SLDB) Gets a Buy from Chardan Capital

TIPRANKS
·
Mar 20

Solid Biosciences files to sell 42.78M shares of common stock for holders

TIPRANKS
·
Mar 20

Solid Biosciences Inc - Prospectus Filed for Resale of up to 1.3 Mln Shares by Selling Stockholder- SEC Filing

THOMSON REUTERS
·
Mar 20

Solid Biosciences Q4 net loss widens on higher R&D costs

Reuters
·
Mar 20

Solid Biosciences reports Q4 EPS (53c), consensus (52c)

TIPRANKS
·
Mar 20

Solid Biosciences Q4 EPS $(0.53) Misses $(0.50) Estimate

Benzinga
·
Mar 20

Solid Biosciences Q4 Net Income USD -49.8 Million

THOMSON REUTERS
·
Mar 20

Press Release: Solid Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 20

Solid Biosciences FY2025 net loss widens 39.8% to USD 174.33 million

Reuters
·
Mar 20